540788 Stock Overview Owns, manages, runs, and administers various diagnostics centers primarily in India. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Aspira Pathlab & Diagnostics Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Aspira Pathlab & Diagnostics Historical stock prices Current Share Price ₹75.46 52 Week High ₹83.93 52 Week Low ₹25.00 Beta -0.38 1 Month Change 24.34% 3 Month Change 37.13% 1 Year Change 108.45% 3 Year Change -12.51% 5 Year Change n/a Change since IPO 433.29%
Recent News & Updates
Aspira Pathlab & Diagnostics Limited to Report Q3, 2025 Results on Feb 07, 2025 Jan 31
Aspira Pathlab & Diagnostics Limited Announces Resignation of Avinash Mahajan as Non-Executive and Independent Director Jan 22
New major risk - Share price stability Dec 17
Aspira Pathlab & Diagnostics Limited to Report Q2, 2025 Results on Nov 12, 2024 Oct 31
Aspira Pathlab & Diagnostics Limited, Annual General Meeting, Sep 27, 2024 Aug 26
First quarter 2025 earnings released: EPS: ₹0.05 (vs ₹0.70 loss in 1Q 2024) Aug 14 See more updates
Aspira Pathlab & Diagnostics Limited to Report Q3, 2025 Results on Feb 07, 2025 Jan 31
Aspira Pathlab & Diagnostics Limited Announces Resignation of Avinash Mahajan as Non-Executive and Independent Director Jan 22
New major risk - Share price stability Dec 17
Aspira Pathlab & Diagnostics Limited to Report Q2, 2025 Results on Nov 12, 2024 Oct 31
Aspira Pathlab & Diagnostics Limited, Annual General Meeting, Sep 27, 2024 Aug 26
First quarter 2025 earnings released: EPS: ₹0.05 (vs ₹0.70 loss in 1Q 2024) Aug 14
Aspira Pathlab & Diagnostics Limited to Report Q1, 2025 Results on Aug 13, 2024 Aug 03
Full year 2024 earnings released: ₹2.60 loss per share (vs ₹0.086 loss in FY 2023) May 30
Aspira Pathlab & Diagnostics Limited to Report Q4, 2024 Results on May 28, 2024 May 20
Third quarter 2024 earnings released: ₹0.72 loss per share (vs ₹0.43 profit in 3Q 2023) Feb 14
Aspira Pathlab & Diagnostics Limited Announces Resignation of Arvind Bhanushali as Non-Executive, Non-Independent Director and as Member of Audit Committee Feb 13
Aspira Pathlab & Diagnostics Limited to Report Q3, 2024 Results on Feb 10, 2024 Feb 02
New minor risk - Share price stability Jan 24
Aspira Pathlab & Diagnostics Limited to Report Q2, 2024 Results on Nov 11, 2023 Oct 28
Aspira Pathlab & Diagnostics Limited Appoints Manas Mengar as the Member of Nomination and Remuneration Committee Oct 18
Aspira Pathlab & Diagnostics Limited Announces Completion of Tenure of Subhash Raghunath Salunke as Non-Executive and Independent Director Sep 29
Aspira Pathlab & Diagnostics Limited Appoints Manas Mengar as Non-Executive and Independent Director Sep 28
Aspira Pathlab & Diagnostics Limited, Annual General Meeting, Sep 26, 2023 Aug 15
First quarter 2024 earnings released: ₹0.70 loss per share (vs ₹0.28 loss in 1Q 2023) Aug 13
Aspira Pathlab & Diagnostics Limited Announces Appointment of Krupali Shah as Company Secretary Cum Compliance Officer Aug 13
Aspira Pathlab & Diagnostics Limited to Report Q1, 2024 Results on Aug 12, 2023 Jul 28
Aspira Pathlab & Diagnostics Limited Announces the Resignation of Priya Pandey as Company Secretary and Compliance Officer, Key Managerial Personnel Jun 26
Full year 2023 earnings released: ₹0.09 loss per share (vs ₹4.33 profit in FY 2022) May 30
Now 21% undervalued after recent price drop May 26
Now 22% undervalued after recent price drop Mar 16
Third quarter 2023 earnings released: EPS: ₹0.43 (vs ₹0.84 in 3Q 2022) Feb 16
Aspira Pathlab & Diagnostics Limited to Report Q3, 2023 Results on Feb 14, 2023 Feb 07
Insufficient new directors Nov 16
Aspira Pathlab & Diagnostics Limited Approves the Change in Designation of Arvind Bhanushali from Executive Director to Non-Executive Director Nov 13
Aspira Pathlab & Diagnostics Limited to Report Q2, 2023 Results on Nov 12, 2022 Nov 06
Investor sentiment improved over the past week Sep 26
Insider recently sold ₹410k worth of stock Sep 25
Investor sentiment deteriorated over the past week Aug 25
Aspira Pathlab & Diagnostics Limited to Report Q1, 2023 Results on Aug 13, 2022 Jul 28
Investor sentiment improved over the past week Jul 20
Aspira Pathlab & Diagnostics Limited to Report Q4, 2022 Results on May 28, 2022 May 21
Insufficient new directors Apr 27
Insufficient new directors Apr 19
Aspira Pathlab & Diagnostics Limited Approves Appointment of Priya Pandey as Company Secretary and Compliance Officer of the Company Apr 17
Company Secretary & Compliance Officer Devyangi Patel has left the company Oct 03
Company Secretary & Compliance Officer Devyangi Patel has left the company Sep 29
Aspira Pathlab & Diagnostics Limited to Report Q3, 2021 Results on Feb 13, 2021 Feb 06
Aspira Pathlab & Diagnostics Limited Announces Resignation of Mamta Mav as Company Secretary & Compliance Officer Jan 15
Aspira Pathlab & Diagnostics Limited to Report Q1, 2021 Results on Jul 28, 2020 Jul 26 Shareholder Returns 540788 IN Healthcare IN Market 7D -2.9% -2.1% -1.8% 1Y 108.5% 19.1% 6.2%
See full shareholder returns
Return vs Market: 540788 exceeded the Indian Market which returned 6.2% over the past year.
Price Volatility Is 540788's price volatile compared to industry and market? 540788 volatility 540788 Average Weekly Movement 6.1% Healthcare Industry Average Movement 5.5% Market Average Movement 6.3% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.3%
Stable Share Price: 540788 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 540788's weekly volatility (6%) has been stable over the past year.
About the Company Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. It offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016.
Show more Aspira Pathlab & Diagnostics Limited Fundamentals Summary How do Aspira Pathlab & Diagnostics's earnings and revenue compare to its market cap? 540788 fundamental statistics Market cap ₹776.71m Earnings (TTM ) -₹19.09m Revenue (TTM ) ₹152.38m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 540788 income statement (TTM ) Revenue ₹152.38m Cost of Revenue ₹104.19m Gross Profit ₹48.19m Other Expenses ₹67.29m Earnings -₹19.09m
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 07, 2025
Earnings per share (EPS) -1.85 Gross Margin 31.63% Net Profit Margin -12.53% Debt/Equity Ratio 27.4%
How did 540788 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/31 18:28 End of Day Share Price 2025/01/31 00:00 Earnings 2024/06/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Aspira Pathlab & Diagnostics Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
